Kalbe Farma (KLBF) booked unaudited net profit of Rp1.92 trillion last year, grew 10.8% from 2012, while sales revenue increased by 17.4% to Rp16.01 trillion. This is a strong performance because it represents almost Rp38 earning per share. Another consumer player Ultrajaya (ULTJ), meanwhile, plans to build a new milk processing facility.

To subscribe please click here